Literature DB >> 20153879

Current status on tissue factor activation of factor VIIa.

Egon Persson1, Ole H Olsen.   

Abstract

Free factor VIIa displays a zymogen-like behavior with low intrinsic activity. Formation of a complex between factor VIIa and tissue factor is necessary to enhance the procoagulant activity of factor VIIa, not only by providing membrane localization, substrate exosites and positioning the active site at an appropriate distance above the surface but also by allosteric enhancement of the enzymatic activity, and this event signals initiation of blood coagulation. The interaction is of high affinity and all the domains are engaged at the interface. The crosstalk between the protease domain of factor VIIa, in particular residue Met-306, and the N-terminal domain of tissue factor provides the starting point for the allosteric activation of factor VIIa. The pathway(s) of conformational transitions in factor VIIa ensuing tissue factor binding has not been entirely mapped. The present paper is a brief compilation of our current knowledge of the allosteric mechanism by which tissue factor induces and stabilizes the active conformation of factor VIIa. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153879     DOI: 10.1016/j.thromres.2010.01.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways.

Authors:  Lisbeth M Andersen; Peter A Andreasen; Ivan Svendsen; Janneke Keemink; Henrik Østergaard; Egon Persson
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation.

Authors:  Sang Mee Hwang; Ji-Eun Kim; Kyou-Sup Han; Hyun Kyung Kim
Journal:  Crit Care       Date:  2011-04-14       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.